Study of a Respiratory Syncytial Virus candidate formulation in adults aged 60 years and older

Trial Identifier: VAE00017
Sponsor: Sanofi Pasteur, a Sanofi Company
Start Date: April 2024
Primary Completion Date: March 2025
Study Completion Date: March 2025
Condition: Respiratory Syncytial Virus Immunisation; Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Australia, Queensland Sippy Downs, Queensland, Australia, 4556
Australia, Queensland Southport, Queensland, Australia, 4222
Australia, Victoria Camberwell, Victoria, Australia, 3124
AUSTRALIA Norwood, AUSTRALIA, 5067
AUSTRALIA, New South Wales Botany, New South Wales, AUSTRALIA, 2019
Chile Santiago, Chile, 7500657
Chile, Biobío Concepcion, Biobío, Chile, 4070094
Chile, Reg Metropolitana de Santiago Santiago, Reg Metropolitana de Santiago, Chile, 8380453
Chile, Reg Metropolitana de Santiago Santiago, Reg Metropolitana de Santiago, Chile, 8420383
CHILE Santiago, CHILE, 7510157
CHILE, Reg Metropolitana de Santiago Santiago, Reg Metropolitana de Santiago, CHILE, 7580206
Colombia AGUAZUL, Colombia, 856010
Colombia Barranquilla, Colombia, 080020
Colombia Cali, Colombia, 76001
Colombia IBAGUE, Colombia, 730001
COLOMBIA Bogota, COLOMBIA, 110111
COLOMBIA Girardot, COLOMBIA, 252431
COLOMBIA Quindio, COLOMBIA, 630001
Dominican Republic Santo Domingo, Dominican Republic, 10205
Honduras Tegucugalpa, Honduras, 11101
HONDURAS San Pedro Sula, HONDURAS, 21104
HONDURAS Tegucigalpa, HONDURAS, 11101
Mexico, Guanajuato Leon, Guanajuato, Mexico, 37000
MEXICO Queretaro, MEXICO, 76100